Clinical Trials Directory

Trials / Unknown

UnknownNCT00662090

Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood

Prospective Non-randomized Multi-center Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood

Status
Unknown
Phase
Study type
Observational
Enrollment
260 (estimated)
Sponsor
University Hospital Freiburg · Academic / Other
Sex
All
Age
215 Months
Healthy volunteers
Not accepted

Summary

The aim of the study is to improve the accuracy of diagnosis for children and adolescents with MDS by a standardized review of morphology and standardized cytogenetic and molecular analysis. The primary objectives of the study are: * To evaluate the frequency of the different subtypes of MDS in childhood and adolescence by a standardized diagnostic approach * To evaluate the frequency of cytogenetic and molecular abnormalities: Specifically using array-CGH to evaluate the frequency of subtle chromosomal imbalances, i.e. gains and losses of defined chromosomal regions, and amplifications. Specifically using mFISH to identify unknown chromosomal aberrations, particularly subtle translocations involving new candidate genes, and to better define chromosomal breakpoints. The secondary objectives of the study are: * To assess survival for children and adolescents with MDS and JMML * To evaluate relapse rate, morbidity and mortality in children with MDS and JMML treated by HSCT

Conditions

Timeline

Start date
2006-01-01
Primary completion
2023-12-01
Completion
2024-12-01
First posted
2008-04-21
Last updated
2023-05-24

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00662090. Inclusion in this directory is not an endorsement.